Brand names: SOLTAMOX, Nolvadex
12.1 Mechanism of Action Tamoxifen is an estrogen agonist/antagonist. Tamoxifen competes with estrogen for binding to the estrogen receptor, which can result in a decrease in estrogen receptor signaling-dependent growth in breast tissue. Tamoxifen has demonstrated antitumor activity against human breast cancer cell lines xenografted in mice. The drug has been shown to inhibit the induction of rat mammary carcinoma induced by dimethylbenzanthracene (DMBA) and to cause the regression of already established DMBA-induced tumors.
Contraindications
10 documented side effects by frequency
No community discussions found for TAMOXIFEN CITRATE yet.
Every figure on this page links back to its primary source. See data sources for full provenance.
3 available comparisons
Dosage Forms
Tablet
Route
Oral